DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
DOTAMTATE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOTAMTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1637.88
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CAL-263
1
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
PI3-kinase p110-delta subunit inhibitor
CAL-263
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RGB-286638
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
Cyclin-dependent kinase 1 inhibitor
RGB-286638
×
Maximum Phase:
1
First Approval:
None
UNII:
1GAJ98SC2X
Molecule Type:
Small molecule
Molecular Formula:
C29H35N7O4
Molecular Weight:
545.64
AlogP:
2.42
PSA:
115.06
HBD:
3.0
HBA:
#RotB:
8.0
Source:
METHYLDOPA (RACEMIC)
1
Small molecule
Investigational
Unknown
Unknown
Hypertension; Hypotension, Orthostatic; Orthostatic Intolerance
Unknown
METHYLDOPA (RACEMIC)
×
Maximum Phase:
1
First Approval:
None
UNII:
33TD13T99R
Molecule Type:
Small molecule
Molecular Formula:
C10H13NO4
Molecular Weight:
211.22
AlogP:
0.44
PSA:
103.78
HBD:
4.0
HBA:
#RotB:
3.0
Source:
TTC-352
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
TTC-352
×
Maximum Phase:
1
First Approval:
None
UNII:
65ILH3Y0MI
Molecule Type:
Small molecule
Molecular Formula:
C20H13FO3S
Molecular Weight:
352.39
AlogP:
5.91
PSA:
49.69
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FANAPANEL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FANAPANEL
×
Maximum Phase:
1
First Approval:
None
UNII:
E3AP71EM0O
Molecule Type:
Small molecule
Molecular Formula:
C14H15F3N3O6P
Molecular Weight:
409.26
AlogP:
0.68
PSA:
124.86
HBD:
3.0
HBA:
#RotB:
3.0
Source:
APTO-253
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
APTO-253
×
Maximum Phase:
1
First Approval:
None
UNII:
WB59MRW00U
Molecule Type:
Small molecule
Molecular Formula:
C22H14FN5
Molecular Weight:
367.39
AlogP:
5.26
PSA:
70.25
HBD:
2.0
HBA:
#RotB:
1.0
Source:
MU-BC-1
1
Antibody
Investigational
Unknown
Unknown
Unknown
Fibronectin binding agent
MU-BC-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLAPTESED PEGOL
1
Unknown
Investigational
Unknown
Unknown
Glioblastoma; Pancreatic Neoplasms
Unknown
OLAPTESED PEGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
MTM792B442
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SONIFILAN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SONIFILAN
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABCD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ABCD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYC-065
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms
Unknown
CYC-065
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZADIRACHTA INDICA
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZADIRACHTA INDICA
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDOLE-3-CARBINOL
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Tobacco Use Disorder; Obesity
Unknown
INDOLE-3-CARBINOL
×
Maximum Phase:
1
First Approval:
None
UNII:
C11E72455F
Molecule Type:
Small molecule
Molecular Formula:
C9H9NO
Molecular Weight:
147.18
AlogP:
1.66
PSA:
36.02
HBD:
2.0
HBA:
#RotB:
1.0
Source:
GSK-625433
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-625433
×
Maximum Phase:
1
First Approval:
None
UNII:
2YAD6KT0NT
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O5S
Molecular Weight:
512.63
AlogP:
4.02
PSA:
106.78
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HIGENAMINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HIGENAMINE
×
Maximum Phase:
1
First Approval:
None
UNII:
TBV5O16GAP
Molecule Type:
Small molecule
Molecular Formula:
C16H17NO3
Molecular Weight:
271.32
AlogP:
2.23
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
2.0
Source:
ONC-392
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ONC-392
×
Maximum Phase:
1
First Approval:
None
UNII:
4R46M31XXP
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADG-106
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Unknown
ADG-106
×
Maximum Phase:
1
First Approval:
None
UNII:
I4QM8E7Y2R
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986115
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-986115
×
Maximum Phase:
1
First Approval:
None
UNII:
LSK1L593UU
Molecule Type:
Small molecule
Molecular Formula:
C26H25F7N4O3
Molecular Weight:
574.5
AlogP:
4.77
PSA:
113.65
HBD:
3.0
HBA:
#RotB:
9.0
Source:
ASP-4058
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASP-4058
×
Maximum Phase:
1
First Approval:
None
UNII:
01J7526K2Q
Molecule Type:
Small molecule
Molecular Formula:
C19H12F6N4O2
Molecular Weight:
442.32
AlogP:
5.63
PSA:
76.83
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TRV-120027
1
Protein
Investigational
Unknown
Unknown
Heart Failure; Severe Acute Respiratory Syndrome
Unknown
TRV-120027
×
Maximum Phase:
1
First Approval:
None
UNII:
J1J4P3PQZD
Molecule Type:
Protein
Molecular Formula:
C43H67N13O10
Molecular Weight:
926.09
AlogP:
-1.91
PSA:
355.05
HBD:
13.0
HBA:
#RotB:
26.0
Source:
RG-7603
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Serine/threonine-protein kinase mTOR inhibitor
RG-7603
×
Maximum Phase:
1
First Approval:
None
UNII:
579255I6O9
Molecule Type:
Small molecule
Molecular Formula:
C24H32N6O3
Molecular Weight:
452.56
AlogP:
2.27
PSA:
91.85
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SNDX-5613
1
Small molecule
Investigational
Unknown
Unknown
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Menin/Histone-lysine N-methyltransferase MLL inhibitor
SNDX-5613
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C76H106F2N12O20S2
Molecular Weight:
1609.88
AlogP:
4.68
PSA:
107.97
HBD:
1.0
HBA:
#RotB:
11.0
Source:
SD-0006
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
SD-0006
×
Maximum Phase:
1
First Approval:
None
UNII:
C57VF8YO91
Molecule Type:
Small molecule
Molecular Formula:
C20H20ClN5O2
Molecular Weight:
397.87
AlogP:
2.89
PSA:
95.0
HBD:
2.0
HBA:
#RotB:
4.0
Source:
MESCALINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MESCALINE
×
Maximum Phase:
1
First Approval:
None
UNII:
RHO99102VC
Molecule Type:
Small molecule
Molecular Formula:
C11H17NO3
Molecular Weight:
211.26
AlogP:
1.21
PSA:
53.71
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LUXEPTINIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute
Unknown
LUXEPTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
TQ6PBX1JU0
Molecule Type:
Small molecule
Molecular Formula:
C25H17F4N5O2
Molecular Weight:
495.44
AlogP:
5.5
PSA:
98.91
HBD:
4.0
HBA:
#RotB:
4.0
Source:
HSV1716
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HSV1716
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK2879552
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Myelodysplastic Syndromes; Small Cell Lung Carcinoma
Unknown
GSK2879552
×
Maximum Phase:
1
First Approval:
None
UNII:
GT77Z6Y09Z
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O2
Molecular Weight:
364.49
AlogP:
3.74
PSA:
52.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
DSTP3086S
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
DSTP3086S
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-8353
1
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms
MAP kinase ERK1 inhibitor
MK-8353
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NONA-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NONA-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARC-19499
1
Unknown
Investigational
Unknown
Unknown
Hemophilia A
Unknown
ARC-19499
×
Maximum Phase:
1
First Approval:
None
UNII:
0493WH50VT
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENANTHRENE
1
Small molecule
Investigational
Unknown
Unknown
Tobacco Use Disorder
Unknown
PHENANTHRENE
×
Maximum Phase:
1
First Approval:
None
UNII:
448J8E5BST
Molecule Type:
Small molecule
Molecular Formula:
C14H10
Molecular Weight:
178.23
AlogP:
3.99
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
TEMANOGREL
1
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Serotonin 2a (5-HT2a) receptor inverse agonist
TEMANOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
F42Z27575A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O4
Molecular Weight:
436.51
AlogP:
3.06
PSA:
77.85
HBD:
1.0
HBA:
#RotB:
8.0
Source:
1
2
…
116
117
118
119
120
121
122
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA